Answers
is showing signs of symptoms beyond what is considered early detection?
Perhaps I should clarify....I am wondering what is considered early detection. Is onset of symptoms past early detection? Thus, what seems like a much lower cure rate...
Early detection is when you have a colonoscopy and they find a nodule, then remove it.
Having symptoms is past earliest detection but if having any symptoms you should see your Dr. immediately. Many other things besides cancer have similar symptoms.
Colonoscopy is the most comprehensive for detecting colorectal cancer. Dr. Manny reviews what happens during the procedure. Aired by FOXNEWS ...
I would just try webmd, that's a good place to start. If you're concerned, one easy test that you should take is the OBT (occult blood test). This is a test where your feces is inspected to find trace amounts of blood that might indicate a lesion of the bowels. I get this test each year with my phsyical, it is one great test for early detection I tell you. I am a nurse and know of one man who got the test from his doctor but never did it until it was too late, he had to have surgery and stuff to remove the cancer later on down the road, I'm not sure if he had a full recovery but better to find something sooner than later. God bless
Is this test a real test? If it is and it is as effective as they say it is, why are people not getting this test yearly like a mammogram, pap, or colon check?
What do you know about this test?
amihealth.tripod.com/amas.htm
read the page and you may find what u need.
Price: $17.95
Symptoms, detection, prevention and cure of colon cancer.
Colon Cancer Causes
Most colorectal cancers arise from adenomatous polyps—clusters of abnormal cells in the glands covering the inner wall of the colon. Over time, these abnormal growths enlarge and ultimately degenerate to become adenocarcinomas.
People with any of several conditions known as adenomatous polyposis syndromes have a greater-than-normal risk of colorectal cancer.
In these conditions, numerous adenomatous polyps develop in the colon, ultimately leading to colon cancer.
The cancer usually occurs before age 40 years.
Adenomatous polyposis syndromes tend to run in families. Such cases are referred to as familial adenomatous polyposis (FAP). Celecoxib (Celebrex) has been FDA approved for FAP. After 6 months, celecoxib reduced the mean number of rectal and colon polyps by 28% compared to placebo (sugar pill) 5%.
Colon Cancer Symptoms
Cancer of the colon and rectum can exhibit itself in several ways. If you have any of these symptoms, seek immediate medical help.
You may notice bleeding from your rectum or blood mixed with your stool.
People commonly attribute all rectal bleeding to hemorrhoids, thus preventing early diagnosis owing to lack of concern over "bleeding hemorrhoids."
Rectal bleeding may be hidden and chronic and may show up as an iron deficiency anemia.
It may be associated with fatigue and pale skin.
It usually, but not always, can be detected through a fecal occult (hidden) blood test, in which samples of stool are submitted to a lab for detection of blood.
If the tumor gets large enough, it may completely or partially block your colon. You may notice the following symptoms of bowel obstruction:
Abdominal distension: Your belly sticks out more than it did before without weight gain.
Abdominal pain: This is rare in colon cancer. One cause is tearing (perforation) of the bowel. Leaking of bowel contents into the pelvis can cause inflammation (peritonitis) and infection.
Unexplained, persistent nausea or vomiting
Unexplained weight loss
Change in frequency or character of stool (bowel movements)
Small-caliber (narrow) or ribbon-like stools
Sensation of incomplete evacuation after a bowel movement
Rectal pain: Pain rarely occurs with colon cancer and usually indicates a bulky tumor in the rectum that may invade surrounding tissue.
Studies suggest that the average duration of symptoms (from onset to diagnosis) is 14 weeks. There is no association between overall duration of symptoms and the stage of your tumor.
Prevention
Your best prevention is to detect colon cancer and treat it early in its formation. People who have regular screening for colon cancer, including fecal occult blood tests, sigmoidoscopy or colonoscopy, and polyp removal, greatly reduce their risk of having a colorectal cancer.
Other things you can do to lower your risk include the following:
Quit smoking. Smoking cigarettes has been clearly linked with higher risk of colon cancer (as well as many other conditions).
Take an aspirin or baby aspirin every day. Because of potential side effects, this is not recommended for everyone. Talk to your health care provider first.
Take a safe dose of folic acid (for example, 1 mg) every day.
Engage in physical activity every day.
Eat a variety of fruits and vegetables every day.
The US Agency for Health Care Policy and Research recommends screening for colon cancer in people older than 50 years who have an average risk for the disease and in people aged 40 years and older who have a family history of colorectal cancer. The agency recommends that one of the following screening techniques be used:
Fecal occult blood testing every year combined with flexible sigmoidoscopy every 5 years
Double-contrast barium enema every 5-10 years
Colonoscopy every 10 years: Colonoscopy remains the most sensitive test for detecting colon polyps and tumors.
Once polyps have been identified, they should be removed. After you have had polyps, even one polyp, you should begin to have more frequent colonoscopies.
Appropriate preventive screening for people with ulcerative colitis includes the following:
Colonoscopy every 1-2 years in the following cases:
If you have known you have the disease for 7-8 years
If the cancer involves the entire colon
Beginning 12-15 years after the diagnosis of left-sided colitis
Random colon biopsies taken during colonoscopy
People with ulcerative colitis in whom biopsies show premalignant changes should undergo surgical removal of their colons.
Outlook
Recovery from colon cancer depends on the extent of your disease before your surgery.
If your tumor is limited to the inner layers of your colon, you can expect to live 5 years or more.
If cancer has spread to your lymph nodes adjacent to the colon, the chance of living 5 years is 65%.
If the cancer has already spread to other organs, the chance of living 5 years drops to 8%.
If the cancer has reached your liver but no other organs, removing part of your liver may prolong your life.
1
Colon cancer is right behind (no pun intended) lung cancer and heart disease as the biggest threat to your mortality. And to think you would have survived with early detection. Cheez! Okay, a little smelly but so what? Are you so stupid that you'd rather die than submit a stool sample to your family doctor? Give your butt a break or Rest in Peace.
Some people would rather "Die from Embarrassment" than be poked and prodded up there.
I'm a rectal cancer survivor. So I've gone through every indignity possible that is associated with butt cancer.
A colonoscopy is a piece of cake, a bit uncomfortable, but that's it.
They caught my cancer early, stage 2, so I only needed surgery to cure me. No Chemo no Radiation.
Honestly, the Doctors and Nurses who choose to work in this field, bless 'em, do so because they want to save lives. They work with "poo, pus and pee everyday". , my Surgeons words, and it doesn't bother them in the least, so it shouldn't bother you.
Buy Cheap
Rosetta Genomics' Diagnostic Program Update (NASDAQ:ROSG) | FavStocks
The conference will held from November 9 to November 11 in Hong Kong where they will present a new generation of molecular diagnostic markers that will help in the treatment and diagnosis of colon cancer. Rosetta Genomics is one of the leading molecular diagnostics companies that develops and commercializes molecular diagnostic products based on its proprietary microRNAs. The company is also developing and discovering early detection cancer screening products, including a colon cancer screening test. Rosetta Genomics have their labs in Philadelphia where they perform commercial molecular diagnostics tests in order to discover and develop new diagnostics markers.
During the update, Rosetta Genomics pointed out that colon cancer serum project is still in the early stage of development, and the company cannot provide any assurance that it will be successful in developing this product in its intended timeframe, or at all. Also the company cannot assure that the final product will effectively differentiate colon cancer from other types of cancers. However, the company has a commercial product called miRview that can identify around 25 types of cancer and help them work on the colon cancer alone. Rosetta Genomics also updated that they have identified the microRNA potential biomarkers on serum samples obtained from colon cancer patients in comparison to samples derived from control individuals. The company is still gathering more data for further validation and are constantly reviewing the behavior of microRNA in health individuals and comparing it with patients who are suffering from colon cancer.
News
NCI Seeking Licensee for Colorectal Cancer Biomarkers, Methods of DetectionGenomeWeb Daily News - Dec 11, 2009
The National Cancer Institute this week made available for licensing protein biomarkers and methods for the detection of colorectal cancer.Florida Times-Union - Dec 10, 2009
Little About (blog)An annual report from the American Cancer Society and other groups predicts that colon cancer will drop over the next decade and, by 2020, could even be US cancer rate declines: studyUS Cancer Cases, Deaths Continue to DropCancer Rates Decline Across The Board, But Some Types On The Rise - -all 133 news articles »
NewsWest9.com - Dec 09, 2009
TriCities.comPruitt says the largest progress was seen with breast cancer and colon cancer, in part due to early detection. He says these results are encouraging, Experts: Colon cancer deaths could make big dropCancer Death Rates and Diagnoses Among Americans Continue to DeclineGet adequate fiber in diet to maintain healthy colon - -all 408 news articles »
PR Newswire (press release) - Dec 11, 2009
In addition to the widely adopted Oncotype DX breast cancer test, Genomic Health is preparing to launch its Oncotype DX colon cancer test in the first and more »USA Today - Dec 09, 2009
"Having some soy in the diet is probably a good thing, especially if it replaces red meat," which is linked to an increased risk of colon cancer, he says. and more »Villages Daily Sun - Dec 10, 2009
Twenty years ago, the target was prostate cancer, and death rates took a tremendous drop. “This decade, colon cancer was targeted, and the need for Cancer deaths rates are downall 2 news articles »Ninemsn - Dec 11, 2009
Colon cancer kills 90 Australians every week but the common detection procedure is one that takes lots of practice for doctors to master. and more »



Colon Cancer: Current And Emerging Trends In Detection
Colon Cancer: Current and Emerging Trends in Detection
Colon Cancer: Current And Emerging Trends In Detection